---
id: 1523384935717150720
author: 1098323148662018064
published_date: 2022-05-08 19:30:46 +00:00
conversation_id: 1522997158550462466
---
@stephensenn @yudapearl @RWJE_BA Good point, so the question is how to describe two separate studies that happen to share a treatment (in TARGET case it was lumiracoxib). They might as well be TARGET1 and TARGET2. Also what would be the common estimate of interest?